GeNeuro SA Profile Avatar - Palmy Investing

GeNeuro SA

GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody, which has completed Phase IIb clinical tr…

Biotechnology
CH, Plan-les-Ouates [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Value per Employee (VpE)

No VpE graphs at the moment.

Employee Surveys

Employees Asked: -

No survey available at the moment.

Talent Acquisition

Permanent Employees

Last 12 Months:
Wage Range
Employees: -
Min.:$n/A
Avg.:$n/A
Max.:$n/A
Highest Demand Within Q3:

GeNeuro SA can't present the data

Top Demand Within Q3:

Not available for GeNeuro SA

Temporary Employees H1Bs

Last 12 Months:
Wage Range
Employees: -
Min.:$n/A
Avg.:$n/A
Max.:$n/A
Highest Demand Within Q3:

GeNeuro SA can't present the data

Top Demand Within Q3:

    Not available for GeNeuro SA

geographical
binding & acquisition

U.S. · Company Locations
Worldwide · Talent Acquisition
End of GNRO.PA's Analysis
CIK: - CUSIP: H33418106 ISIN: CH0308403085 LEI: - UEI: -
Secondary Listings
GNRO.PA has no secondary listings inside our databases.